"Neurovascular guidewires market to exhibit lucrative growth during the forecast period"
The global neurovascular guidewires market is growing expressively, was valued at US$ 313.1 Mn in 2022, and is expected to reach US$ 465.3 Mn by 2034. Rising cardiovascular disorders along with demand for minimally invasive procedures will drive the overall neurovascular guidewires market growth globally. Evolution in guidewire technology along with rising acceptance for wrapped guidewires would also drive the overall market during the forecast period.
"Wrapped guidewire segment is expected to register higher growth by the end of 2034"
The global sale of neurovascular-wrapped guidewires is increasing significantly, mainly in the Asia Pacific, and Europe. The coating facilitates access past obstructions and negotiates through tortuous anatomy. Also provides low coefficient of friction to facilitate progression and catheter tracking. Other major factors driving the growth include product expansion for guidewires with hydrophobic or hydrophilic coating (guidewire technology) among neurologists, advancement in fluoropolymer coatings, and utilization of hybrid guidewires along with higher precision and safety will drive the growth of the market.
"Nitinol (nickel- titanium alloy) segment is expected to register higher growth by the end of 2034"
Nitinol hydrophilic guidewires are gaining traction slowly in developing markets. The properties of nitinol guidewires such as flexibility, stiffness, low friction navigation, torqueability and hydrophilic coating plays vital role during the treatment procedures. Other major factors enhancing the material type segment include increasing minimally invasive procedures in the radiology angiographic and cardiology procedures, reduced cost and advanced guidewire technology.
"Heart in the application segment generated maximum revenue share in 2022"
As per the recent data provided by the Centers for Disease Control and Prevention, more than 800,000 individuals in the U.S. experience stroke every year. Around 50 million surgical procedures are performed every year in the U.S. Neurovascular guidewires are majorly utilized to carry catheters, stents, and balloons to cure cerebral aneurysms or arteriovenous malformations. Nearby 2% to 3% of the global population suffers from cerebral aneurysm.
"Increasing ageing population in the developed nations will drive the market growth during the forecast period"
Growing population along with prevalence of cardiovascular and neurological disorders will drive the demand in the hospitals. Additionally, demand for minimally invasive treatment procedures due to its advantages over open surgeries, less complications, and shorter hospital stay along with growing neurovascular cases is generating a noteworthy revenue share in the global market. However, deficiency of skilled physicians, less availability of branded products, high cost and no or less reimbursement are factors restraining the growth of neurovascular guidewires market on a global scale.
"Increasing demand for advanced products and the presence of established players hold the U.S. in dominant position"
The U.S. generated maximum revenue share in the global neurovascular guidewires market. Additionally, swift commercialization of innovative medical devices will drive the growth in North America. Partnerships, new technology expansion in the guidewire technology, demand for hybrid products, and growing cardiovascular procedures will further spur revenue growth in the U.S. market. The massive patient population in emerging nations, improvised reimbursement structure, and partnerships of medical device companies will drive market growth on a global scale.
"Dominance of multinational manufacturers with strong product portfolio in the developed regions"
Major players in the neurovascular guidewires market are Stryker Corporation, Cardinal Health, Inc., Boston Scientific Corporation, Cook Medical Incorporated, Medtronic, Inc., Abbott Laboratories, Cordis Corp., ASAHI INTECC CO., LTD., St. Jude Medical, Inc., Lepu Medical Technology (Beijing) Co., Ltd., Terumo Medical Corporation, Integra LifeSciences Corporation, Conmed Corporation, and others. Companies are executing growth strategies through new guidewire technology, new product launch, and technology expansion to hospitals and neurological centers.
Historical & Forecast Period
This study report represents analysis of each segment from 2024 to 2034 considering 2025 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2026 to 2034.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Neurovascular Guidewires market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2024-2034 |
| Base Year | 2025 |
| Forecast Period | 2026-2034 |
| Historical Year | 2024 |
| Unit | USD Million |
| Segmentation | |
Type
|
|
Material
|
|
Application
|
|
End User
|
|
|
Region Segment (2024-2034; US$ Million)
|
Key questions answered in this report
